Not available
Quote | AtriCure Inc. (NASDAQ:ATRC)
Last: | $23.17 |
---|---|
Change Percent: | -5.33% |
Open: | $23.92 |
Close: | $23.17 |
High: | $24.17 |
Low: | $23.12 |
Volume: | 947,750 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
News | AtriCure Inc. (NASDAQ:ATRC)
2024-04-23 08:34:50 ET More on AtriCure AtriCure, Inc. (ATRC) Q4 2023 Earnings Call Transcript AtriCure Q4 2023 Earnings Preview Seeking Alpha’s Quant Rating on AtriCure Historical earnings data for AtriCure Financial information for AtriCure ...
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it has launched the cryoSPHERE ® + cryoablation probe, leve...
Message Board Posts | AtriCure Inc. (NASDAQ:ATRC)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $ATRC News Article - AtriCure to Participate in the Oppenheimer 33rd Annual Healthcare | whytestocks | investorshangout | 02/17/2023 1:40:52 PM |
whytestocks: $ATRC News Article - AtriCure to Participate in the 41st Annual J.P. Morgan Healthcare | whytestocks | investorshangout | 12/20/2022 4:50:46 PM |
whytestocks: $ATRC News Article - AtriCure Reports Preliminary Results for Fourth Quarter and Full Y | whytestocks | investorshangout | 01/10/2022 5:45:48 PM |
whytestocks: $ATRC News Article - AtriCure, inc (ATRC) Q3 2021 Earnings Call Transcript | whytestocks | investorshangout | 11/04/2021 5:30:52 PM |
whytestocks: $ATRC News Article - AtriCure's EPi-Sense System Approved by FDA for Treatment of Long- | whytestocks | investorshangout | 04/29/2021 12:35:51 PM |
News, Short Squeeze, Breakout and More Instantly...
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it has launched the cryoSPHERE ® + cryoablation probe, leve...
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its first quarter 2024 financial results on Wednesday, M...
A look at the top 10 most actives in the United States Kintara Therapeutics Inc. (KTRA) rose 99.9% to $0.2007 on volume of 121,318,217 shares Next.e.GO N.V. (EGOX) rose 30.8% to $0.034 on volume of 63,981,361 shares C3is Inc. (CISS) rose 20.8% to $0.0494 on volume of 63,446,681 shares I...